MedPath

CORIA LABORATORIES, LTD.

CORIA LABORATORIES, LTD. logo
🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

7

Active:0
Completed:7

Trial Phases

3 Phases

Phase 1:2
Phase 2:1
Not Applicable:4

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (7 trials with phase data)• Click on a phase to view related trials

Not Applicable
4 (57.1%)
Phase 1
2 (28.6%)
Phase 2
1 (14.3%)

Effect of Tetrix on Alleviation of Burning,Itching Associated With Lesions of Contact Dermatitis

Not Applicable
Completed
Conditions
Contact Dermatitis
First Posted Date
2008-03-31
Last Posted Date
2008-05-22
Lead Sponsor
Coria Laboratories, Ltd.
Target Recruit Count
44
Registration Number
NCT00646867
Locations
🇺🇸

Dermatology Specialists, LLC, Louisville, Kentucky, United States

Evaluation of Tetrix Cream as a Protective Barrier Against Injurious Materials

Not Applicable
Completed
Conditions
Healthy
First Posted Date
2008-03-26
Last Posted Date
2008-05-22
Lead Sponsor
Coria Laboratories, Ltd.
Target Recruit Count
36
Registration Number
NCT00643630
Locations
🇺🇸

Dermatolgoy Specialists, LLC, Louisville, Kentucky, United States

Evaluation of Tetrix Cream in the Healing of Injured Skin in Subjects With Contact Dermatitis

Not Applicable
Completed
Conditions
Healthy
First Posted Date
2008-03-26
Last Posted Date
2008-05-22
Lead Sponsor
Coria Laboratories, Ltd.
Target Recruit Count
12
Registration Number
NCT00643214
Locations
🇺🇸

Dermatology Specialists, LLC, Louisville, Kentucky, United States

Study to Determine if Tetrix Cream is Removed From the Hands by Gentle Washing With Soap and Water

Not Applicable
Completed
Conditions
Healthy
First Posted Date
2008-03-26
Last Posted Date
2008-03-28
Lead Sponsor
Coria Laboratories, Ltd.
Target Recruit Count
10
Registration Number
NCT00644436
Locations
🇺🇸

Dermatology Consulting Services, High Point, South Carolina, United States

A Study to Determine the Safety and Efficacy of Atralin (Tretinoin 0.05%) Gel for the Treatment of Rosacea

Phase 2
Completed
Conditions
Rosacea
Interventions
First Posted Date
2008-02-22
Last Posted Date
2008-12-18
Lead Sponsor
Coria Laboratories, Ltd.
Target Recruit Count
36
Registration Number
NCT00621218
Locations
🇺🇸

Product Investigations, Inc., Conshohocken, Pennsylvania, United States

  • Prev
  • 1
  • 2
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.